68872-84-4

Upstream product

• 1666-13-3 diphenyl diselenide 
• 96-32-2 bromoacetic acid methyl ester 
• 77086-38-5 ketene t-butyldimethylsilyl methyl acetal 
• 591-51-5 phenyllithium 
• 645-96-5 Benzeneselenol 
• 66003-76-7 Diphenyliodonium triflate 
• 2179-79-5 phenyl selenocyanate 
• 5707-04-0 Phenylselenyl chloride 
• 23974-72-3 sodium phenylselenide 
• 180846-04-2 4-Phenylselanylcarbonyl-decanoic acid methyl ester 
• 67-56-1 methanol 
• 73194-20-4 2-chloro-2,2-difluoroethyl phenyl selenide 
• 186581-53-3 diazomethane 
• 76529-39-0 methyl (phenylseleno)formate 

Downstream Products

• 22146-93-6 cis-Methyl-3-methylhex-2-enoat 
• 22146-94-7 (E)-3-methyl-hex-2-enoic acid methyl ester 
• 624-45-3 levulinic acid methyl ester 
• 1666-13-3 diphenyl diselenide 
• 84574-19-6 3-Chloro-benzoic acid methoxycarbonyl-phenylselanyl-methyl ester 
• 180846-04-2 4-Phenylselanylcarbonyl-decanoic acid methyl ester 
• 124650-83-5 Methyl-2-phenylseleno-3-hydroxy-3-phenylpropionat 

Relevant academic research and scientific papers

Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma

Multidrug resistance (MDR) in cancer cells is a crucial aspect to consider for a successful cancer therapy. P-gp/ABCB1, a member of ABC transporters, is involved in the main tumour MDR mechanism, responsible for the efflux of drugs and cytotoxic substances. Herein, we describe a discovery of potent selenium-containing ABCB1 MDR efflux pump modulators with promising anticancer activity. On three groups of selenoethers comprehensive studies in terms of design, synthesis, and biological assays, including an insight into cellular mechanisms of anticancer action as well as an ADMET-screening in vitro were performed, followed by in-depth SAR analysis. Among the investigated new phenylselenoether hybrids, four compounds showed significant cytotoxic and anti-proliferative effects, in particular, in resistant cancer cells. Hydantoin derivatives (5–7) were significantly more effective than the reference inhibitor verapamil (up to 2.6-fold at a 10-fold lower concentration) modulating ABCB1-efflux pump, also possessing a good drug-drug interaction profile. The best compound (6) was further evaluated in human JURKAT T-lymphocytic cancer cells for its impact on cell proliferation rate. Mechanistically, the expression of cyclin D1, an enhancer of the cell cycle, decreases, while p53, an inhibitor of cell proliferation, was up-regulated upon the treatment with compound 6 alone or in combination with the chemotherapeutic agent doxorubicin. In summary, a new chemical space of highly active selenium-containing anticancer agents has been discovered, with a new lead compound 6 that warrants more in-depth biological evaluation and further pharmacomodulation.

Synthesis and computer-aided SAR studies for derivatives of phenoxyalkyl-1,3,5-triazine as the new potent ligands for serotonin receptors 5-HT6

This research has provided the most active 5-HT6R agents among 1,3,5-triazine derivatives investigated to date and has also identified the world's first selenium-containing 5-HT6R ligands. The studies are focused on design, synthesis, biological evaluation and docking-supported SAR analysis for novel 5-HT6R agents as derivatives of lead structure 4-(4-methylpiperazin-1-yl)-6-(phenoxymethyl)-1,3,5-triazin-2-amine (7). The lead modifications included an introduction of: (i) various small substituents at benzene ring, (ii) a branched ether linker or (iii) the ether oxygen replacement with other chalcogen (S, Se) or sulfonyl moiety. Hence, a series of new compounds (7–24) was synthesized and examined on their affinities for 5-HT6R and selectivity, in respect to the 5-HT1AR, 5-HT2AR, 5-HT7R and dopamine D2 receptor, in the radioligand binding assays. For representative most active compounds functional bioassays and toxicity profile in vitro and antidepressant-like activity in vivo were examined. The 2-isopropyl-5-methylphenyl derivative (10) was found as the most active triazine 5-HT6R antagonist (Ki = 11 nM). SAR analysis indicated, that an exchange of oxygen to selenium (7 vs. 22), and especially, to sulfur (7 vs. 19) was beneficial to increase both affinity and antagonistic action for 5-HT6R. Surprisingly, an introduction of SO2 caused a drastic decrease of the 5-HT6R affinity, which was explained at a molecular level based on docking studies. All in vivo tested compounds (10, 18 and 21) did not show any risk of toxicity in the safety studies in vitro.

Rhodium-Catalyzed Rearrangement of S/Se-Ylides for the Synthesis of Substituted Vinylogous Carbonates

An efficient rhodium-catalyzed unprecedented oxa-[2,3]-sigmatropic rearrangement of sulfur ylide derived from α-thioesters/ketones and diazo carbonyl compounds has been accomplished for the synthesis of various sulfur-tethered vinylogous carbonates in good to excellent yields. Important features of the developed reaction include wide functional group tolerance, excellent chemo- and regioselectivity, and efficient rearrangement involving the carbonyl motif. The present reaction also equally works well with α-selenoesters for the synthesis of seleno-containing vinylogous carbonates.

Direct biocatalysed synthesis of first sulfur-, selenium- and tellurium- containing l-ascorbyl hybrid derivatives with radical trapping and GPx-like properties

6-O-l-Ascorbyl selenoesters, thioesters and telluroesters can be efficiently and directly prepared from l-ascorbic acid and suitable functionalised chalcogenoesters through lipase-catalysed transesterification reactions. Novel synthesised l-ascorbyl deriv

Metal-free synthesis of unsymmetrical organoselenides and selenoglycosides

A one-pot, metal-free procedure has been developed to synthesize unsymmetrical organoselenides. In the first step of the reaction, arylation of potassium selenocyanate (KSeCN) with an iodonium reagent proceeds in the absence of a metal catalyst to produce

Synthesis of diorganyl selenides mediated by zinc in ionic liquid

Figure presented A new approach for the synthesis of diorganyl selenides is described. By using economically attractive zinc dust in BMIM-BF4, a series of diorganyl selenides were efficiently achieved in excellent yields, under neutral reaction conditions. Compared to the usual organic solvents, BMIM-BF4 exhibited higher performance with the advantage to be reused up to five successive runs.

A novel synthesis of unsymmetrical selenides via the cleavage of Se-Se bond by Sm/cat.CoCl2 system

Promoted by Sm/cat. CoCl2 system, the Se-Se bond of diaryldiselenides was easily cleaved to form a "living" intermediate, which reacted readily with alkyl halides to afford unsymmetrical alkylarylselenides in good yields under mild and neutral reaction conditions.

Reductive cleavage of Se-Se bond by Sm/NiCl2 or Sm/NiCl 2.6H2O system: A novel preparation of unsymmetrical aryl selenides

The Sm/NiCl2 or Sm/NiCl2.6H2O system promoted diarylselenides to react with alkyl halides to afford unsymmetrical aryl selenides in good yields under mild and neutral conditions.

Group transfer carbonylations: Photoinduced alkylative carbonylation of alkenes accompanied by phenylselenenyl transfer

The photolysis of methyl α-(phenylseleno)acetate (1b) and related compounds in the presence of an alkene and CO leads to acyl selenides 2 via group transfer carbonylation. The mechanism of this three-component coupling reaction involves the addition of a (methoxycarbonyl)methyl radical to an alkene, the trapping of the produced alkyl free radical by CO, and termination of the reaction by a phenylselenenyl group transfer from the starting material.

New methodology for the synthesis of unsaturated 8-, 9- and 10-membered lactams

Unsaturated 8-, 9- and 10-membered medium ring lactams 1 (n = 1, 2, 3) have been prepared in good yield by the Claisen rearrangement of the vinyl-substituted precursors 3 in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU).